Suigen PRDC Formulation: Each 1 mL (dose) contains: Bordetella bronchiseptica -1 OD Bordetella bronchiseptica (DNT)-200 ug/mL Pasteurella multocida (Type A and D)-I OD P. multocida Type A (OMP)-30 ug/mL Actinobacillus pleuropneumoniae (Serotype 2 and 5)-1 OD P. multocida Type D (DNT)-200 ug/mL Mycoplasma hvopneumoniae-0.12 OD A. pleuropneumoniae Serotype 2 and 5 (Toxin) 10 ug/mL Streptococcus suis (Type 2)-0.45 OD Haemophilus parasuis (Serotype 1, 4 and 5)-0.45 OD OD - Optical Density at 410 nm absorbance (ELISA) DNT – Dermonecrotic Toxin OMP - Outer Membrane Protein Suspension for Injection (IM)

Pays: Philippines

Langue: anglais

Source: FDA (Food And Drug Administration)

Ingrédients actifs:

Inactivated Bordetella bronchiseptica , Pasteurella multocida , Actinobacillus pleuropneumoniae , Mycoplasma hyopneumoniae , Streptococcus suis , Haemophilus parasuis Vaccine (Vet.)

Disponible depuis:

Virbac Philippines Inc.; Distributor: Virbac Philippines Inc.

DCI (Dénomination commune internationale):

Inactivated Bordetella bronchiseptica + Pasteurella multocida + Actinobacillus pleuropneumoniae + Mycoplasma hyopneumoniae + Streptococcus suis + Haemophilus parasuis Vaccine (Vet.)

Dosage:

Formulation: Each 1 mL (dose) contains: Bordetella bronchiseptica -1 OD Bordetella bronchiseptica (DNT)-200 ug/mL Pasteurella multocida (Type A and D)-I OD P. multocida Type A (OMP)-30 ug/mL Actinobacillus pleuropneumoniae (Serotype 2 and 5)-1 OD P. multocida Type D (DNT)-200 ug/mL Mycoplasma hvopneumoniae-0.12 OD A. pleuropneumoniae Serotype 2 and 5 (Toxin) 10 ug/mL Streptococcus suis (Type 2)-0.45 OD Haemophilus parasuis (Serotype 1, 4 and 5)-0.45 OD OD - Optical Density at 410 nm absorbance (ELISA) DNT – Dermonecrotic Toxin OMP - Outer Membrane Protein

forme pharmaceutique:

Suspension for Injection (IM)

Unités en paquet:

White PP Bottle Sealed with Bromobutyl Rubber Stopper and Alu Cap x 50 mL (Box of 10's)

Fabriqué par:

KBNP, Inc., Korea

Date de l'autorisation:

2022-03-07